好评率
100%
  • Cao Y; Yao W; Yang T, et al., Elucidating the mechanisms of Buyang Huanwu Decoction in treating chronic cerebral ischemia: A combined approach using network pharmacology, molecular docking, and in vivo validation. Phytomedicine 2024, 132, 155820.
    IF: 6.7
    Year: 2024 Journal: Phytomedicine
    PubMed: 39004032
  • Li N; Du Z; Li Y, et al., p57 Suppresses the Pluripotency and Proliferation of Mouse Embryonic Stem Cells by Positively Regulating p53 Activation. Stem Cells Int 2021, 2021, 4968649.
    IF: 5.443
    Year: 2021 Journal: Stem Cells Int
    PubMed: 34976070
  • Qi A; Ru W; Yang H, et al., Circular RNA ACTA1 Acts as a Sponge for miR-199a-5p and miR-433 to Regulate Bovine Myoblast Development through the MAP3K11/MAP2K7/JNK Pathway. J Agric Food Chem 2022.
    IF: 5.279
    Year: 2022 Journal: J Agric Food Chem
    PubMed: 35234473
  • Zhu N; Meng S; Mao L, et al., Amino polycarboxylic acids-modified abiraterone derivatives as potential injectable anti-prostate cancer agents. Bioorg Chem 2024, 153, 107824.
    IF: 4.5
    Year: 2024 Journal: Bioorg Chem
    PubMed: 39305608
  • Lu T; Zheng Y; Chen X, et al., miR-743b-3p promotes hepatic lipogenesis via branched-chain amino acids (BCAA) metabolism by targeting PPM1K in aged mice. Arch Gerontol Geriatr 2024, 123, 105424.
    IF: 4
    Year: 2024 Journal: Arch Gerontol Geriat
    PubMed: 38565071
  • Guo J; Tang Q; Wang Q, et al., Pifithrin-alpha enhancing anticancer effect of topotecan on p53-expressing cancer cells. Eur J Pharm Sci 2019, 128, 61-72.
    IF: 3.466
    Year: 2018 Journal: Eur J Pharm Sci
    PubMed: 30472223
  • Fan Y; Ma K; Jing J, et al., Recombinant Dual-target MDM2/MDMX Inhibitor Reverses Doxorubicin Resistance through Activation of the TAB1/TAK1/p38 MAPK Pathway in Wild-type p53 Multidrug-resistant Breast Cancer Cells. J Cancer 2020, 11 (1), 25-40.
    IF: 3.182
    Year: 2020 Journal: J Cancer
    PubMed: 31892970
0
产品咨询微信

服务热线

400-602-0407

APP下载
生物狗小程序